The emergence of new respiratory viruses, such as SARS-CoV-2 and avian influenza, has highlighted the importance of understanding and monitoring the transmission of airborne pathogens within healthcare facilities.
Viruses, bacteria, and fungi can circulate through the air and contribute to transmission risks, impacting both patient safety and healthcare staff. Yet many airborne microorganisms remain difficult to detect using traditional monitoring methods.
In this context, bioaerosol monitoring has become a valuable tool for assessing exposure risks, strengthening infection control strategies, and supporting safer healthcare environments.
In our White Paper, discover best practices for bioaerosol monitoring, along with several real-world applications conducted in healthcare settings using Coriolis® Air Samplers for the rapid detection and monitoring of airborne pathogens.
